Processa Pharmaceuticals, Inc. (PCSA) Social Stream
Processa Pharmaceuticals Inc (PCSA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PCSA.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued January 27, 2022
The Trend in the Analyst Price Target
PCSA's average price target has moved down $1 over the prior 33 weeks.
PCSA reports an average of 181.96% for its upside potential over the past 43 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PCSA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 153 days, PCSA's average broker recommendation rating improved by 1.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, Processa Pharmaceuticals Inc's number of analysts covering the stock is greater than 9.34% of them.
- PCSA has a higher upside potential (average analyst target price relative to current price) than 380.83% of all US stocks.
- PCSA has a lower variance in analysts' estimates than 50.06% of Pharmaceutical Products stocks.
- In terms of how Processa Pharmaceuticals Inc fares relative to Healthcare stocks, note that its average analyst price target is greater than 110.53% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Processa Pharmaceuticals Inc are ORGS, ONCS, and OGEN.
Is PCSA a Buy, Hold or Sell? See the POWR Ratings now!